<DOC>
	<DOCNO>NCT00702520</DOCNO>
	<brief_summary>The objective trial evaluate whether corifollitropin alfa ( MK-8962 , Org 36286 ) treatment induction multifollicular growth woman undergo Controlled Ovarian Stimulation ( COS ) prior vitro fertilization ( IVF ) Intracytoplasmic Sperm Injection ( ICSI ) safe pregnant participant offspring .</brief_summary>
	<brief_title>Pregnancy Neonatal Follow-up Ongoing Pregnancies Established Clinical Trial 38833 ( P05783 )</brief_title>
	<detailed_description>This follow-up protocol prospectively monitor pregnancy , delivery , neonatal outcome woman treat corifollitropin alfa become pregnant base Trial 38833 . For follow-up trial ( 38834 ) , investigational product administer study specific assessment require , information obtain per standard clinical practice .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Participants receive one dose corifollitropin alfa Trial 38833 ; Ongoing pregnancy confirm ultrasound least 10 week embryo transfer Trial 38833 ; Able willing give write informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Neonatal outcome</keyword>
	<keyword>Congenital malformation</keyword>
	<keyword>In-Vitro fertilization</keyword>
	<keyword>Controlled ovarian stimulation</keyword>
	<keyword>Follow-up</keyword>
</DOC>